🇺🇸 FDA
Patent

US 8287879

Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use

granted A61KA61K2039/522A61K2039/523

Quick answer

US patent 8287879 (Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use) held by The Regents of the University of California expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K2039/522, A61K2039/523, A61K39/04, A61P